论文部分内容阅读
目的在输血过程中应用筛检不规则抗体,分析其临床应用价值。方法回顾性分析我院自2015年4月至2016年4月期间所收治的126例行筛检不规则抗体检测患者的临床资料,作为观察组;另选取我院同期所收治的126例未行筛检不规则抗体检测患者作为对照组,对比2组患者的组间数据。结果观察组患者的输血反应发生率显著性低于对照组,差异性显著且P<0.05,统计学意义存在。结论在输血过程中应用筛检不规则抗体的临床应用价值较高,可降低输血反应发生率。
Objective To detect irregular antibodies during blood transfusion and analyze its clinical value. Methods A retrospective analysis of our hospital from April 2015 to April 2016 were treated 126 cases of screening for detection of irregular antibodies in patients with clinical data, as the observation group; the other selected the same period in our hospital 126 cases did not line Screening irregular antibody test patients as a control group, comparing two groups of patients between the data. Results The incidence of transfusion reaction in observation group was significantly lower than that in control group, with significant difference (P <0.05). There was statistical significance. Conclusion The application of screening for irregular antibodies during transfusion is of high clinical value and can reduce the incidence of transfusion reactions.